Results 111 to 120 of about 4,732 (172)

Pleasant Odor Decreases Mouse Anxiety-like Behaviors by Regulating Hippocampal Endocannabinoid Signaling. [PDF]

Int J Mol Sci
Bi JR, Zha HW, Gao QL, Wu H, Liu ZJ, Sun D.   +5 more
europepmc   +1 more source

Correction: Tetrahydrocannabinol and dopamine D1 receptor. [PDF]

Front Neurosci
Lee J.
europepmc   +1 more source

Allosteric Modulation of Cannabinoid Type 1 Receptor by ZCZ011: Integration of In Vitro Pharmacology and Molecular Dynamics Simulation. [PDF]

ACS Bio Med Chem Au
Yadav TC, Swaminathan LI, Chirasani VR, Wu Z, Lu D, Ignatowska-Jankowska BM, Lichtman AH, Fitting S, Yadav-Samudrala BJ.   +8 more
europepmc   +1 more source

Cannabinoid CB₁ Receptor Activation Mitigates <i>N</i>‑Methyl‑d‑aspartate Receptor-Mediated Neurotoxicity. [PDF]

ACS Pharmacol Transl Sci
Navarro G, Raïch I, Rebassa JB, Lillo J, Pérez-Olives C, Capó T, Cubeles E, Saura CA, Cordomí A, Sotelo E, Reyes-Resina I, Franco R.   +11 more
europepmc   +1 more source

Revealing the therapeutic potential of synthetic cannabinoids: a systematic review of cannabinoid receptor binding dynamics and their implications for cancer therapy. [PDF]

J Cannabis Res
Alghamdi SS, Albahlal HN, Aloumi DE, Bin Saqyah S, Alsubait A, Alamre J, Alrashed M, Alsuhabeny N, Mohammed AE.   +8 more
europepmc   +1 more source

The Endocannabinoid System in the Development and Treatment of Obesity: Searching for New Ideas. [PDF]

Int J Mol Sci
Serefko A, Lachowicz-Radulska J, Jach ME, Świąder K, Szopa A.   +4 more
europepmc   +1 more source

Weight regain after cessation of medication for weight management: systematic review and meta-analysis.

BMJ
West S, Scragg J, Aveyard P, Oke JL, Willis L, Haffner SJP, Knight H, Wang D, Morrow S, Heath L, Jebb SA, Koutoukidis DA.   +11 more
europepmc   +1 more source